Since 1974, tire Expanded Programme on Immunization (EPI) has provided
technical support for the immunization of the world's children and wo
men of childbearing age. Today, the vast majority of vaccines administ
ered to these groups are delivered through the immunization programmes
that have been established in developing countries. As these national
programmes share many characteristics, the global use of a new or imp
roved vaccine could be largely dependent on its compatibility with the
priorities, existing antigens and vaccine delivery system of this net
work. Consequently, a framework has been developed for the systematic
evaluation of candidate vaccines for use in EPI.